Artikel ; Online: Early investigational antibiotics for the treatment of acute exacerbations of chronic bronchitis.
Expert opinion on investigational drugs
2017 Band 26, Heft 3, Seite(n) 313–317
Abstract: Introduction: Acute exacerbations in patients with chronic bronchitis are a leading cause of hospitalizations and death. Bacteria contribute significantly to such exacerbations. The aim of this review was to explore the potential role of investigational ...
Abstract | Introduction: Acute exacerbations in patients with chronic bronchitis are a leading cause of hospitalizations and death. Bacteria contribute significantly to such exacerbations. The aim of this review was to explore the potential role of investigational antibiotics in the treatment of these episodes. Areas covered: The available literature in PubMed database, in websites related to investigational drugs and in websites of the producing companies has been searched. The in vitro activity against pathogens involved in acute exacerbations of chronic bronchitis and the pharmacokinetic profile of antibiotics currently under development were taken into consideration for inclusion in the review. Expert opinion: Several novel antimicrobial agents have completed preclinical and Phase I studies and were well-tolerated. Further investigation is mandatory in order to evaluate their future in treatment of chronic bronchitis exacerbations and discover potential advantages compared to already approved antimicrobials. |
---|---|
Mesh-Begriff(e) | Acute Disease ; Animals ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/pharmacokinetics ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; Bacterial Infections/pathology ; Bronchitis, Chronic/drug therapy ; Bronchitis, Chronic/microbiology ; Bronchitis, Chronic/pathology ; Drug Design ; Drugs, Investigational/adverse effects ; Drugs, Investigational/pharmacokinetics ; Drugs, Investigational/therapeutic use ; Humans |
Chemische Substanzen | Anti-Bacterial Agents ; Drugs, Investigational |
Sprache | Englisch |
Erscheinungsdatum | 2017-03 |
Erscheinungsland | England |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 1182884-5 |
ISSN | 1744-7658 ; 0967-8298 ; 1354-3784 |
ISSN (online) | 1744-7658 |
ISSN | 0967-8298 ; 1354-3784 |
DOI | 10.1080/13543784.2017.1283402 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 3739: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.